MGH Center for Women's Mental Health

About MGH Center for Women's Mental Health

This author has not yet filled in any details.
So far MGH Center for Women's Mental Health has created 1457 blog entries.

Prenatal Exposure to Benzodiazepines and Sedative-Hypnotics

Over the last decade, we have seen multiple studies looking at the long term effects of prenatal exposure to antidepressants, particularly the selective serotonin reuptake inhibitors or SSRIs, on children's behavior.  Although benzodiazepines, such as [...]

By |2020-01-07T16:57:49-04:00August 31st, 2017|Anti-Anxiety Medications, Pregnancy & Medications, Sleep Medications|Comments Off on Prenatal Exposure to Benzodiazepines and Sedative-Hypnotics

National Pregnancy Registry for Atypical Antipsychotics Milestone

  We are excited to announce the enrollment of our 1000th participant in the National Pregnancy Registry for Atypical Antipsychotics! Formed in 2008, the Registry was established at MGH to prospectively evaluate the rates of [...]

By |2017-08-23T13:49:59-04:00August 23rd, 2017|Antipsychotic Medications, Pregnancy & Medications|Comments Off on National Pregnancy Registry for Atypical Antipsychotics Milestone

New Research from the CWMH: Patterns of Atypical Antipsychotic Use During Pregnancy

  The use of the newer “atypical” or second-generation antipsychotic agents is increasing.  Atypical antipsychotics are now used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety [...]

By |2017-08-21T11:24:36-04:00August 21st, 2017|Antipsychotic Medications, Pregnancy & Medications, Research at CWMH|Comments Off on New Research from the CWMH: Patterns of Atypical Antipsychotic Use During Pregnancy

Weekly Roundup for AUGUST 18, 2017: Recent Publications in Women’s Mental Health

Brandlistuen and colleagues look at the long-term effects of prenatal exposure to benzodiazepines and sedative-hypnotics, attempting to control for genetic and environmental confounds by using sibling-controlled comparisons.  Using data from Danish registers, Liu and colleagues [...]

By |2017-08-23T22:35:43-04:00August 20th, 2017|Weekly Roundup|Comments Off on Weekly Roundup for AUGUST 18, 2017: Recent Publications in Women’s Mental Health

Maternal Smoking During Pregnancy Associated with Psychiatric Illness in Offspring

  In the United States, the prevalence of smoking in pregnant women has declined; however, according to data gathered from 29 states by the Pregnancy Risk Assessment Monitoring System (PRAMS), about 13% of women smoked [...]

By |2017-08-17T09:38:28-04:00August 17th, 2017|Nicotine, Perinatal Substance Use, Psychiatric Disorders During Pregnancy|Comments Off on Maternal Smoking During Pregnancy Associated with Psychiatric Illness in Offspring

New Study at the CWMH: Course of ADHD During Pregnancy and the Postpartum

  About 1.4 million people in the U.S. have been diagnosed with ADHD, and about 60-80% of children diagnosed with ADHD will need to take their medication into adulthood. When girls diagnosed in childhood become [...]

By |2017-08-16T09:58:46-04:00August 16th, 2017|ADHD, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on New Study at the CWMH: Course of ADHD During Pregnancy and the Postpartum

Prescribing Psychotropic Medications with Opioids During Pregnancy May Increase Risk for Neonatal Withdrawal

  Illicit opioid use has steadily increased over the past decade, and this increase is most prominent in the 18–25 age group, which includes women of reproductive age (Substance Abuse and Mental Health Services Administration, [...]

By |2017-08-09T10:18:55-04:00August 9th, 2017|Opioids, Perinatal Substance Use, Pregnancy & Medications|Comments Off on Prescribing Psychotropic Medications with Opioids During Pregnancy May Increase Risk for Neonatal Withdrawal

France Bans the Use of Valproic Acid in Some Women of Childbearing Age

There have long been concerns regarding the safety of the anticonvulsant valproate (Depakote) during pregnancy.  Back in 2009, the American Academy of Neurology and American Epilepsy Society recommended against the use of valproic acid in [...]

By |2017-08-11T08:57:58-04:00August 7th, 2017|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on France Bans the Use of Valproic Acid in Some Women of Childbearing Age

Announcing the MGH Perinatal Depression Scale at the App Store

We are very pleased to announce the release of the MGH Perinatal Depression Scale available free of charge on the App Store (https://appsto.re/us/-3X4jb.i). The MGHPDS smartphone app includes digital versions of perinatal depression screening tools [...]

By |2017-11-21T11:17:10-04:00August 2nd, 2017|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on Announcing the MGH Perinatal Depression Scale at the App Store
Go to Top